‘Chemical Hyperthyroidism’: Serum Triiodothyronine Levels in Clinically Euthyroid Individuals Treated with Levothyroxine

Duncan Salmon, Marc Rendell, Julia Williams, Cynthia Smith, David A. Ross, John M. Waud, John Eager Howard

Research output: Contribution to journalArticle

Abstract

We have observed many patients treated with levothyroxine sodium who have elevated serum thyroxine (T4) levels but appear clinically euthyroid. Such patients generally have normal serum triiodothyronine (T3) values. A retrospective review at The Johns Hopkins Hospital, Baltimore, comparing the correlation of T3 and T4 values in levothyroxine-treated patients with that in patients not so treated was carried out from 1977 to 1979. Mean free thyroxine index (FTI) value in 104 levothyroxine-treated patients was 4.70 ± 0.2 and mean T3 value was 177 ± 9 ng/dL. In a group of 50 hyperthyroid patients, mean FTI value was 7.26 ± 0.5, with a mean T3 value of 389 ± 26 ng/dL. In 71 euthyroid patients, mean FTI value was 2.36 ± 0.1, with a T3 value of 137 ± 3 ng/dL. Computed ratios of T3 to FTI and T3 to T4 were significantly lower in the group treated with levothyroxine than in either the hyperthyroid or euthyroid nontreated groups. Levothyroxine-treated patients with high T4 levels but normal T3 levels were clinically euthyroid. Patients not treated with levothyroxine with similarly elevated T4 levels had elevated T3 levels and were clinically hyperthyroid. It is concluded that lower relative T3 levels in levothyroxine-treated patients may explain why these patients appear clinically euthyroid despite elevated T4 values. Serum T3 determination is the procedure of choice for evaluation of levothyroxine-treated individuals. Furthermore, an elevated FTI value in such an individual does not, in itself, dictate need to reduce dosage.

Original languageEnglish
Pages (from-to)571-573
Number of pages3
JournalArchives of Internal Medicine
Volume142
Issue number3
DOIs
StatePublished - 1982
Externally publishedYes

Fingerprint

Triiodothyronine
Hyperthyroidism
Thyroxine
Serum
Baltimore

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

‘Chemical Hyperthyroidism’ : Serum Triiodothyronine Levels in Clinically Euthyroid Individuals Treated with Levothyroxine. / Salmon, Duncan; Rendell, Marc; Williams, Julia; Smith, Cynthia; Ross, David A.; Waud, John M.; Howard, John Eager.

In: Archives of Internal Medicine, Vol. 142, No. 3, 1982, p. 571-573.

Research output: Contribution to journalArticle

Salmon, Duncan ; Rendell, Marc ; Williams, Julia ; Smith, Cynthia ; Ross, David A. ; Waud, John M. ; Howard, John Eager. / ‘Chemical Hyperthyroidism’ : Serum Triiodothyronine Levels in Clinically Euthyroid Individuals Treated with Levothyroxine. In: Archives of Internal Medicine. 1982 ; Vol. 142, No. 3. pp. 571-573.
@article{f0ca17241ef14d99bd36103c4ae781e1,
title = "‘Chemical Hyperthyroidism’: Serum Triiodothyronine Levels in Clinically Euthyroid Individuals Treated with Levothyroxine",
abstract = "We have observed many patients treated with levothyroxine sodium who have elevated serum thyroxine (T4) levels but appear clinically euthyroid. Such patients generally have normal serum triiodothyronine (T3) values. A retrospective review at The Johns Hopkins Hospital, Baltimore, comparing the correlation of T3 and T4 values in levothyroxine-treated patients with that in patients not so treated was carried out from 1977 to 1979. Mean free thyroxine index (FTI) value in 104 levothyroxine-treated patients was 4.70 ± 0.2 and mean T3 value was 177 ± 9 ng/dL. In a group of 50 hyperthyroid patients, mean FTI value was 7.26 ± 0.5, with a mean T3 value of 389 ± 26 ng/dL. In 71 euthyroid patients, mean FTI value was 2.36 ± 0.1, with a T3 value of 137 ± 3 ng/dL. Computed ratios of T3 to FTI and T3 to T4 were significantly lower in the group treated with levothyroxine than in either the hyperthyroid or euthyroid nontreated groups. Levothyroxine-treated patients with high T4 levels but normal T3 levels were clinically euthyroid. Patients not treated with levothyroxine with similarly elevated T4 levels had elevated T3 levels and were clinically hyperthyroid. It is concluded that lower relative T3 levels in levothyroxine-treated patients may explain why these patients appear clinically euthyroid despite elevated T4 values. Serum T3 determination is the procedure of choice for evaluation of levothyroxine-treated individuals. Furthermore, an elevated FTI value in such an individual does not, in itself, dictate need to reduce dosage.",
author = "Duncan Salmon and Marc Rendell and Julia Williams and Cynthia Smith and Ross, {David A.} and Waud, {John M.} and Howard, {John Eager}",
year = "1982",
doi = "10.1001/archinte.1982.00340160151027",
language = "English",
volume = "142",
pages = "571--573",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - ‘Chemical Hyperthyroidism’

T2 - Serum Triiodothyronine Levels in Clinically Euthyroid Individuals Treated with Levothyroxine

AU - Salmon, Duncan

AU - Rendell, Marc

AU - Williams, Julia

AU - Smith, Cynthia

AU - Ross, David A.

AU - Waud, John M.

AU - Howard, John Eager

PY - 1982

Y1 - 1982

N2 - We have observed many patients treated with levothyroxine sodium who have elevated serum thyroxine (T4) levels but appear clinically euthyroid. Such patients generally have normal serum triiodothyronine (T3) values. A retrospective review at The Johns Hopkins Hospital, Baltimore, comparing the correlation of T3 and T4 values in levothyroxine-treated patients with that in patients not so treated was carried out from 1977 to 1979. Mean free thyroxine index (FTI) value in 104 levothyroxine-treated patients was 4.70 ± 0.2 and mean T3 value was 177 ± 9 ng/dL. In a group of 50 hyperthyroid patients, mean FTI value was 7.26 ± 0.5, with a mean T3 value of 389 ± 26 ng/dL. In 71 euthyroid patients, mean FTI value was 2.36 ± 0.1, with a T3 value of 137 ± 3 ng/dL. Computed ratios of T3 to FTI and T3 to T4 were significantly lower in the group treated with levothyroxine than in either the hyperthyroid or euthyroid nontreated groups. Levothyroxine-treated patients with high T4 levels but normal T3 levels were clinically euthyroid. Patients not treated with levothyroxine with similarly elevated T4 levels had elevated T3 levels and were clinically hyperthyroid. It is concluded that lower relative T3 levels in levothyroxine-treated patients may explain why these patients appear clinically euthyroid despite elevated T4 values. Serum T3 determination is the procedure of choice for evaluation of levothyroxine-treated individuals. Furthermore, an elevated FTI value in such an individual does not, in itself, dictate need to reduce dosage.

AB - We have observed many patients treated with levothyroxine sodium who have elevated serum thyroxine (T4) levels but appear clinically euthyroid. Such patients generally have normal serum triiodothyronine (T3) values. A retrospective review at The Johns Hopkins Hospital, Baltimore, comparing the correlation of T3 and T4 values in levothyroxine-treated patients with that in patients not so treated was carried out from 1977 to 1979. Mean free thyroxine index (FTI) value in 104 levothyroxine-treated patients was 4.70 ± 0.2 and mean T3 value was 177 ± 9 ng/dL. In a group of 50 hyperthyroid patients, mean FTI value was 7.26 ± 0.5, with a mean T3 value of 389 ± 26 ng/dL. In 71 euthyroid patients, mean FTI value was 2.36 ± 0.1, with a T3 value of 137 ± 3 ng/dL. Computed ratios of T3 to FTI and T3 to T4 were significantly lower in the group treated with levothyroxine than in either the hyperthyroid or euthyroid nontreated groups. Levothyroxine-treated patients with high T4 levels but normal T3 levels were clinically euthyroid. Patients not treated with levothyroxine with similarly elevated T4 levels had elevated T3 levels and were clinically hyperthyroid. It is concluded that lower relative T3 levels in levothyroxine-treated patients may explain why these patients appear clinically euthyroid despite elevated T4 values. Serum T3 determination is the procedure of choice for evaluation of levothyroxine-treated individuals. Furthermore, an elevated FTI value in such an individual does not, in itself, dictate need to reduce dosage.

UR - http://www.scopus.com/inward/record.url?scp=84948006085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948006085&partnerID=8YFLogxK

U2 - 10.1001/archinte.1982.00340160151027

DO - 10.1001/archinte.1982.00340160151027

M3 - Article

VL - 142

SP - 571

EP - 573

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 3

ER -